Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Seth Klarman, latest 13F

Orexigen Therapeutics

In Seth Klarman's portfolio · Baupost Group

Ticker OREX

Not in the portfolio as of Q3 2026. Every quarter it shows up in a Baupost Group 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q2 2018 Sell 0  
Q1 2018 No change 2,226,839 0.0% $0.21 $465K
Q4 2017 No change 2,226,839 0.0% $1.29 $2.9M
Q3 2017 No change 2,226,839 0.1% $2.12 $4.7M
Q2 2017 No change 2,226,839 0.1% $2.90 $6.5M
Q1 2017 No change 2,226,839 0.1% $3.44 $7.7M
Q4 2016 No change 2,226,839 0.1% $1.74 $3.9M
Q3 2016 Reduce 90% 2,226,839 0.1% $3.32 $7.4M
Q2 2016 No change 22,268,399 0.1% $0.43 $9.6M
Q1 2016 Add 882% 22,268,399 0.2% $0.56 $12.5M
Q4 2015 Add 176% 2,268,399 0.1% $1.72 $3.9M
Q3 2015 Buy 821,363 0.0% $1.86 $1.5M

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.